Topics

Akebia unveils results on Phase III study for anemia candidate

05:06 EDT 12 Jul 2019 | SmartBrief

Akebia Therapeutics reported that its late-stage study assessing its candidate Riona, or ferric citrate, to treat adults with -More

Original Article: Akebia unveils results on Phase III study for anemia candidate

NEXT ARTICLE

More From BioPortfolio on "Akebia unveils results on Phase III study for anemia candidate"

Quick Search